Algorithmiq develops quantum algorithms and software for molecular structure prediction, drug discovery, and drug design.

Algorithmiq

Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. 
Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems.
We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials

K5 Global

Thames Trust

Tiger Global Management

David Helgason

Feroz Dewan

Haakon Overli

Jorma Ollila

Keenan Rice

When you work for a #quantum algorithm company and even the logo was created by a quantum algorithm 😱. 

How does that even work? Here is the process our Lead Researcher and in-house Brand expert Daniel Cavalcanti went through:

💡 Use quantum algorithms to find the ground state of a water molecule, which is as close to a static snapshot of water as you can get.
💡 Run the algorithm on a quantum computer.
💡 Use the results to generate a set of harmonographs (very cool hypnotic shapes, as you can see below).
💡 Realize that one of the shapes forms the letter A (and is also the prettiest!).

Mind. Blown! 🤯

Here are some of the harmonographs, can you find the one that we selected to become our logo? 

If you enjoyed learning more about the history of #Algorithmiq stay tuned, we are getting ready to end 2024 with a bang! 🔥

Few weeks ago, on July 16th, IBM Quantum and Algorithmiq collaborative research with Harvard Medical School has been presented at ISMB conference, in Montreal 🇨🇦. The feedback was overwhelmingly positive!

🧬 Our joint project focuses on quantum walks for analyzing cell-cell communication networks. Quantum walks, a quantum analog of classical random walks, are powerful tools for investigating the properties of graphs. Their unique characteristics, such as interference and superposition, make them particularly well-suited for identifying and detecting communities within complex networks. The challenges presented by these complex biological networks provide an exciting opportunity to leverage quantum computing for gaining fresh perspectives and making novel discoveries in their analysis. The study contributes to the growing field of network medicine and computational methods for understanding disease progression.

🔑 A key highlight: our quantum walk method discovered metabolites linked to malignancy in adipocytes, which the classical method missed. This result highlights the potential of quantum walks in biomedical research.

We’re excited to extend the work to new data and applications, and we hope to have positive updates soon. Stay tuned!

Filippo Utro, Aritra Bose, Viacheslav Dubovitskii, Ruisheng Wang, Laxmi Parida, Gopal Karemore

🇫🇮Last week, our Q3 hackathon took place!
 
🎯 We spent the first part of the week at our headquarters in Helsinki where, following in the tradition of our hackathons, we reviewed the previous quarter’s OKRs and set next quarter’s focus in line with our overall strategic priorities.

 🎣 The rest of the week was spent in a very special place, Herrankukkaro, a small fishing village on the southern coast of Finland. It's a particularly special place to us because two years ago we gathered there when we were just 15 of us, getting started after having raised our seed round. It’s where we first brainstormed and developed our core values:

📝 Be crazy in thinking but rigorous in verifying
💪 Demonstrate Sisu (a Finnish way of saying ‘to show resilience’)
🔃 Be adaptable
💎 Show trustparency
🤸‍♀️ And remember to have fun along the journey!

🔥 Two years later, we continue to live these values. We’re now over 40 employees and a Series A later with many exciting announcements in store which we’ll be revealing this fall.

🤩 It is immensely thrilling to see first-hand the amount of progress being made, month after month, in the quantum space and it is a privilege to be at the forefront of this progress!

👥 🚀 We're #hiring a new People Operations and Office Manager to join us in our Helsinki HQ! 

👀 🇫🇮 We're looking for a dynamic, passionate and highly organized People Operations and Office Manager who's role will be pivotal in driving our systems and processes for scale, shaping our office culture and fostering a high-performance environment. 

⚡ 🔬It's an amazing opportunity to join our passionate team and work at the intersection between breakthrough quantum computing technologies and the life sciences industry!

🤗 We've created a culture we love and are proud of. We’re a hard-working bunch with a friendly, close-knit, and transparent environment where trust underpins everything we do. As we scale our business, we’re focused on keeping this culture and our values at the heart of our decisions.

➡ Apply or share this opportunity with your networks

🔊 What an amazing way for Algorithmiq to conclude the #ISC24 in Hamburg with our quantum workshop on "Hybrid Quantum/Classical Computing Approaches”co-hosted by Stefan Knecht.

Matea L. presented our recent efforts on “Scalable tensor network based error mitigation” paving the way towards useful quantum advantage.

☀ Way to go!

#ISC24 #Quantum #ISC #High #Performance

At the annual IBM Quantum Partner Forum in Milano earlier this week, we had the pleasure of exchanging, meeting and discussing the latest advancements in the quantum field with the IBM Quantum Network community.
 
It was an enriching few days to hear from Jay Gambetta and Katie Pizzolato on the impressive advancements and roadmap for the IBM Quantum platform and ecosystem and exciting results on utility-scale experiments by Antonio Mezzacapo and others. 

On our side, Sabrina Maniscalco discussed the progress made towards quantum utility across the healthcare and life science vertical working group which includes Cleveland Clinic and IBM, among others. 

Matteo Rossi showcased the latest utility-scale experiments obtained with our drug discovery platform, Aurora and run on IBM’s devices using our error mitigation method in a demo session alongside Michael Biercuk and Netanel Lindner.  

It’s humbling to see how far the field has progressed in the last few years and we’re excited to unveil further advancements in the coming months! 

#IBM #Partner #Forum #Quantum #lifesciences’

Metric
Company Name	Algorithmiq
Symbol
MSH ID	FI:ALGORITHMIQ
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	FI
Stage	Series A
Employee Count	38
Website	algorithmiq.fi
LinkedIn	algorithmiq
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	663
Web Traffic Growth	-0.69
Valuation
Raised Capital	15.34M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

FI:ALGORITHMIQ

Algorithmiq

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue